SI1148873T1 - Visoko preciscena etil EPA in ostali EPA derivati za nevroloske motnje - Google Patents

Visoko preciscena etil EPA in ostali EPA derivati za nevroloske motnje

Info

Publication number
SI1148873T1
SI1148873T1 SI200030748T SI200030748T SI1148873T1 SI 1148873 T1 SI1148873 T1 SI 1148873T1 SI 200030748 T SI200030748 T SI 200030748T SI 200030748 T SI200030748 T SI 200030748T SI 1148873 T1 SI1148873 T1 SI 1148873T1
Authority
SI
Slovenia
Prior art keywords
epa
highly purified
neurological disorders
derivatives
purified ethyl
Prior art date
Application number
SI200030748T
Other languages
English (en)
Inventor
Malcolm Peet
Krishnarao Sitamrao Vaddadi
Original Assignee
Amarin Neuroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9901809.5A external-priority patent/GB9901809D0/en
Application filed by Amarin Neuroscience Ltd filed Critical Amarin Neuroscience Ltd
Publication of SI1148873T1 publication Critical patent/SI1148873T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SI200030748T 1999-01-27 2000-01-21 Visoko preciscena etil EPA in ostali EPA derivati za nevroloske motnje SI1148873T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9901809.5A GB9901809D0 (en) 1999-01-27 1999-01-27 Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
PCT/GB2000/000164 WO2000044361A2 (en) 1999-01-27 2000-01-21 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
EP00900733A EP1148873B1 (en) 1999-01-27 2000-01-21 Highly purified ethyl epa and other epa derivatives for neurological disorders

Publications (1)

Publication Number Publication Date
SI1148873T1 true SI1148873T1 (sl) 2005-12-31

Family

ID=32109055

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030748T SI1148873T1 (sl) 1999-01-27 2000-01-21 Visoko preciscena etil EPA in ostali EPA derivati za nevroloske motnje

Country Status (1)

Country Link
SI (1) SI1148873T1 (sl)

Similar Documents

Publication Publication Date Title
HUP0105215A3 (en) Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
HK1052647A1 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
AU6462500A (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
IL141263A0 (en) Methods for treatment of neurological disorders
HK1044944A1 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
AU6910600A (en) Methods for the treatment of mental disorders
AU3977700A (en) Method of treating neurological disorders
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
GB9926968D0 (en) Treatment of neurological disorders
AU5912900A (en) Quinuclidine derivatives for treatment of neurological disorders
HUP0301553A3 (en) Pharmaceutical compositions and their use for treating neurological disorders
AU2003278084A1 (en) Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders
HUP9904030A3 (en) Use of tiagabine for production of pharmaceutical against psychotic disorders
AU5414100A (en) Chroman derivatives against neurological disorders
SI1148873T1 (sl) Visoko preciscena etil EPA in ostali EPA derivati za nevroloske motnje
EP1053748A4 (en) MEDICINE FOR NEUROLOGICAL DISEASES
HU0700811D0 (en) Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
IL136949A0 (en) 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
AU5689300A (en) Thiochroman derivatives against neurological disorders
AU7521598A (en) Aralkoxy-morphinan derivatives for treatment of cns disorders